These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 17674980)

  • 1. Radiotherapy adapted to spatial and temporal variability in tumor hypoxia.
    Søvik A; Malinen E; Skogmo HK; Bentzen SM; Bruland OS; Olsen DR
    Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1496-504. PubMed ID: 17674980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting the effect of temporal variations in PO2 on tumor radiosensitivity.
    Kirkpatrick JP; Cárdenas-Navia LI; Dewhirst MW
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):822-33. PubMed ID: 15183486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adapting radiotherapy to hypoxic tumours.
    Malinen E; Søvik A; Hristov D; Bruland ØS; Olsen DR
    Phys Med Biol; 2006 Oct; 51(19):4903-21. PubMed ID: 16985278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dosimetric comparison between 2-dimensional radiation therapy and intensity modulated radiation therapy in treatment of advanced T-stage nasopharyngeal carcinoma: to treat less or more in the planning organ-at-risk volume of the brainstem and spinal cord.
    Chau RM; Teo PM; Kam MK; Leung SF; Cheung KY; Chan AT
    Med Dosim; 2007; 32(4):263-70. PubMed ID: 17980826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic contrast enhanced magnetic resonance imaging of bladder cancer and implications for biological image-adapted radiotherapy.
    Røe K; Muren LP; Rørvik J; Olsen DR; Dahl O; Bakke A; Malinen E
    Acta Oncol; 2008; 47(7):1257-64. PubMed ID: 18618299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dosimetric comparison between 3DCRT and IMRT using different multileaf collimators in the treatment of brain tumors.
    Ding M; Newman F; Chen C; Stuhr K; Gaspar LE
    Med Dosim; 2009; 34(1):1-8. PubMed ID: 19181248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of different dose-response parameters on biologically optimized IMRT in breast cancer.
    Ferreira BC; Mavroidis P; Adamus-Górka M; Svensson R; Lind BK
    Phys Med Biol; 2008 May; 53(10):2733-52. PubMed ID: 18448874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A split-organ delineation approach for dose optimisation for intensity-modulated radiotherapy for advanced T-stage nasopharyngeal carcinoma.
    Chau RM; Leung SF; Kam MK; Cheung KY; Kwan WH; Yu KH; Chiu SK; Chan AT
    Clin Oncol (R Coll Radiol); 2008 Mar; 20(2):134-41. PubMed ID: 18031999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Normal tissue complication probability: does simultaneous integrated boost intensity-modulated radiotherapy score over other techniques in treatment of prostate adenocarcinoma.
    Basu KS; Bahl A; Subramani V; Sharma DN; Rath GK; Julka PK
    J Cancer Res Ther; 2009; 5(2):78-84. PubMed ID: 19542662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DCEMRI monitoring of canine tumors during fractionated radiotherapy.
    Søvik A; Kippenes Skogmo H; Bruland ØS; Rune Olsen D; Malinen E
    Acta Oncol; 2008; 47(7):1249-56. PubMed ID: 18618342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison between the ideal reference dose level and the actual reference dose level from clinical 3D radiotherapy treatment plans.
    Bufacchi A; Arcangeli G; delle Canne S; Malatesta T; Capparella R; Fragomeni R; Marmiroli L; Begnozzi L
    Radiother Oncol; 2009 Jul; 92(1):68-75. PubMed ID: 19328571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DCEMRI of spontaneous canine tumors during fractionated radiotherapy: a pharmacokinetic analysis.
    Søvik S; Skogmo HK; Andersen EK; Bruland ØS; Olsen DR; Malinen E
    Radiother Oncol; 2009 Dec; 93(3):618-24. PubMed ID: 19747746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility study of intensity-modulated radiotherapy (IMRT) treatment planning using brain functional MRI.
    Chang J; Kowalski A; Hou B; Narayana A
    Med Dosim; 2008; 33(1):42-7. PubMed ID: 18262122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Large cohort dose-volume response analysis of parotid gland function after radiotherapy: intensity-modulated versus conventional radiotherapy.
    Dijkema T; Terhaard CH; Roesink JM; Braam PM; van Gils CH; Moerland MA; Raaijmakers CP
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1101-9. PubMed ID: 18472355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adapting biological feedback in radiotherapy.
    Søvik A; Malinen E; Olsen DR
    Semin Radiat Oncol; 2010 Apr; 20(2):138-46. PubMed ID: 20219552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor control probability (TCP) and normal tissue complication probability (NTCP) in head and neck cancer.
    Grégoire V
    Rays; 2005; 30(2):105-8. PubMed ID: 16294902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TCP and NTCP in preclinical and clinical research in Europe.
    Baumann M; Petersen C; Krause M
    Rays; 2005; 30(2):121-6. PubMed ID: 16294904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization of tumour control probability in hypoxic tumours by radiation dose redistribution: a modelling study.
    Søvik A; Malinen E; Bruland ØS; Bentzen SM; Olsen DR
    Phys Med Biol; 2007 Jan; 52(2):499-513. PubMed ID: 17202629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of traditional and simultaneous IMRT boost technique basing on therapeutic gain calculation.
    Slosarek K; Zajusz A; Szlag M
    Med Dosim; 2008; 33(4):299-302. PubMed ID: 18973858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical heterogeneity and tumor control probability.
    Eisbruch A
    Acta Oncol; 2010 Nov; 49(8):1385-7. PubMed ID: 20500028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.